newsfilter
← Latest News
GlobeNewswire·

Agomab Announces Results of Annual General Meeting

Antwerp, Belgium, May 27, 2026 – Agomab Therapeutics NV (NASDAQ:AGMB) ("Agomab"), a clinical-stage biopharmaceutical company focused on fibro-inflammation, today announced the results of its Annual General Meeting (AGM)